Volume 9 Supplement 2
Attenuation by a novel synthetic analogue of ACTH4-7 of the learning and memory deficits in juvenile rats treated with amphetamine in utero: role of nitric oxide
© Bashkatova et al; licensee BioMed Central Ltd. 2009
Published: 12 November 2009
Drug abuse among pregnant women continues at alarming frequency. Exposed children often show selective impairments of attention and other disturbances which might develop to major cognitive disorders. This work seeks to examine the impact of prenatal stress (PS) induced by the psychostimulant drug amphetamine (AMPH) on memory functions in male offspring of rats and to study the possible neuroprotective action of the novel Russian peptide Semax (a synthetic analogue of ACTH4-7). In addition, the role of the neuronal messenger nitric oxide (NO) as well as the intensity of lipid peroxidation (LPO) in mechanisms of PS was examined.
Pregnant Wistar rats received a daily intraperitoneal injection of 10 mg/kg AMPH (IUAMPH) or saline for control dams (IUV) between E17 and E20. Nitric oxide generation was measured by electron paramagnetic resonance technique.
Juvenile IUAMPH rats at 25 days of age showed delayed alternation deficits and impairments of acquisition of a fixed platform position in the water maze demonstrating impaired working memory. Both NO and LPO levels were elevated in the hippocampus of IUAMPH rats as compared with control animals. Pretreatment with Semax reversed the PS-induced learning deficits in offspring rats and prevented the increase of NO generation.
Thus, AMPH-elicited PS induces delayed memory deficits and significant learning impairments in juvenile offspring of rats. Therefore, in utero AMPH exposure resulted in a significant oxidative stress, which may be related to impaired learning ability. Modulation of the activity of NO and LPO might lead to a significant recovery of the memory functions in PS rats that open new approaches for neuroprotection and cognitive rehabilitation of prenatal brain damage.
This article is published under license to BioMed Central Ltd.